Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 4, 2002

View Archived Issues

Propecia significantly reduces hair loss, restores hair growth in men with androgenic alopecia

Bivalirudin reduces both thrombotic and bleeding complications in acute coronary syndromes

Pharmacological and pharmacokinetic profile of a new NK3 receptor antagonist

Peripheral COMT inhibitor with optimal properties designed at BIAL

First metabolic drug targets screened in Bayer/CuraGen alliance

Regeneron Q4 and year-end 2001 report

Quintiles and Kos sign commercialization agreement for Advicor and Niaspan

Cyproheptadine as effective as propranolol for neuroleptic-induced akathisia

Approvable letter received for use of Altocor in hypercholesterolemia

Amgen's Neulasta approved for febrile neutropenia

Guilford seeks expansion of indications for Gliadel in Europe

Zometa receives positive opinion for treatment of cancer-related bone metastases

SIGA Technologies' vaccine delivery system completes two clinical trials

Hybrigenics and Mindsense collaborate on biomarkers and drug targets for depression

Infectious disease research collaboration expanded by Cetek and Cubist

Heterocycles under study at Pfizer as inhibitors of 15-lipoxygenase

AHP describes preparation of novel soluble pegylated rapamycin derivatives

Preclinical milestone reached for Crucell human anti-CD46 antibody

Cyclic peptides synthesized for treatment of staphylococcal infections

Chronic inflammation, bone damage attenuated by M-40403 in rat model of arthritis

Factor Xa-inhibitory lactams disclosed by Bristol-Myers Squibb

New compounds identified at City of Hope to inhibit the glycation of proteins

Inhibitors of factor Xa described in patent by Cor Therapeutics

Researchers at Oncopeptides identify melphalan-containing peptides with antitumor activity

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...